Symptoms Spotlight: Diarrhea with Abigail Johnston and Melanie Sisk
Melanie Sisk and Abigail Johnston discuss managing diarrhea from cancer medications—a common but often embarrassing side effect. Learn practical strategies for treatment, when to seek specialist help, and how to advocate for better quality of life during cancer treatment.
Symptoms Spotlight: Fatigue with Abigail Johnston and Melanie Sisk
Join hosts Melanie Sisk and Abigail Johnston as they shine a light on the real experiences of managing cancer symptoms. In each episode of the Symptoms Spotlight series of short episodes, we explore different symptoms caused by cancer or its treatment, sharing practical insights and hard-won wisdom directly from patients who've been there.
Melanie and Abigail share their experiences managing cancer-related fatigue over 5+ years of treatment. They discuss practical solutions including exercise programs like LiveStrong and Two Unstoppable, Medicare fitness benefits, medication options like Ritalin, and the importance of nutrition, hydration, and monitoring vitamin levels.
Front Row: SABCS 2025 Insights with Dr. Francisco Esteva
Join host Victoria Goldberg and Dr. Francisco Esteva as they break down the groundbreaking research from the San Antonio Breast Cancer Symposium 2025. Discover the latest advances in metastatic breast cancer treatment, including new first-line therapies for HER2-positive disease with 40-month progression-free survival, oral SERDs revolutionizing hormone receptor-positive treatment, and antibody drug conjugates transforming triple-negative breast cancer care. Dr. Esteva shares expert insights on brain metastasis prevention, liquid biopsy-guided therapy switching, and how artificial intelligence is reshaping oncology. Whether you're a patient, caregiver, or healthcare professional, this episode offers hope and practical information about the cutting-edge treatments available in 2026.
Live Chat: SERD Surge with Dr. Sherry Shen
Host Victoria, with Dr. Sherry Shen and co-host Ellen, delivers a concise, patient-focused overview of oral SERDs in HR+ metastatic breast cancer—covering ESR1 mutations, key trials (evERA, SERENA‑6), FDA‑approved agents, side-effect management, and treatment implications. This is the first episode in our Live Chats series. Bonus clip: Rebecca Shatsky, MD, previews the evERA trial and her excitement about combining capivasertib with oral SERDs.